Clinical Trials on Beta Lactam Resistant Bacterial Infection in New Zealand

Total 1015 results

Capital and Coast District Health board
Wellington Southern Community Laboratories; Institute of Environmental Science...

Recruiting

Evaluation of a mNGS Workflow for Infection Diagnosis Using Oxford Nanopore Sequencing.

Bacterial Infections

New Zealand
Clinical Directors Network
Patient-Centered Outcomes Research Institute; Rockefeller University

Unknown

Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence (CAMP-2)

Recurrence | Staphylococcal Skin Infections | Antibiotic Resistance | Methicillin-Resistant Staphylococcus Aureus

United States
Menzies School of Health Research
The University of Queensland; Australasian Society for Infectious Diseases; Singapore... and other collaborators

Terminated

Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection (CAMERA2)

Methicillin-Resistant Staphylococcus Aureus

Australia, New Zealand, Israel, Singapore
Global Alliance for TB Drug Development

Completed

A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults

Tuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis Infection

United States
R. Stephen Rankin, M.D.

Unknown

New Mexico Honey Wound Treatment Research Study

Community-acquired Methicillin-resistant Staphylococcus Aureus Infection

United States
Centers for Disease Control and Prevention
Columbia University; New York City Department of Health and Mental Hygiene

Completed

An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment

Tuberculosis | Adherence, Medication | Drug-resistant Tuberculosis | Adherence, Patient

United States
Ellume Pty Ltd

Withdrawn

Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Participants With Acute Pharyngitis

Group A Streptococcal Infection

New Zealand
Cumberland Pharmaceuticals

Completed

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus (ATLAS2)

Staphylococcal Skin Infection

United States
AmtixBio Co., Ltd.
Novotech (Australia) Pty Limited

Completed

A Study of ATB1651 in Adults With Mild to Moderate Onychomycosis

Onychomycosis

New Zealand
AmtixBio Co., Ltd.

Not yet recruiting

A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis

Onychomycosis

New Zealand
Kaleido Biosciences

Terminated

VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant Organisms (VITORA)

Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized Subjects

United States
Horizon Health Network

Completed

Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization

Methicillin-resistant Staphylococcus Aureus

Canada
Pfizer

Completed

Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)

Skin/Soft Tissue Infections | Methicillin Resistant Staphylococcus Aureus (MRSA)

United States, Spain, United Kingdom, Colombia, Italy, Chile, Argentina, Mexico, Belgium, Russian Federation, Brazil, Malaysia, Singapore, Portugal, South Africa, Venezuela
Ochsner Health System
GlaxoSmithKline; Tulane University School of Medicine

Withdrawn

Efficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal Colonization

Methicillin-resistant Staphylococcus Aureus

United States
Janssen Infectious Diseases BVBA

Withdrawn

A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis

Multi-drug Resistant Tuberculosis

China, Ukraine, Taiwan, Korea, Republic of, Peru, Brazil, Estonia, Latvia, Philippines, Russian Federation, South Africa, Thailand, Turkey, Georgia, Mexico, Cambodia, Ethiopia
University Hospital of Cologne
Charite University, Berlin, Germany; University Hospital Tuebingen; University... and other collaborators

Completed

Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives (ABSOLUTE)

Clostridium Difficile Infection | Nosocomial Infection | VRE Infection | MRGN Bacteria

Germany
AbbVie

Completed

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Bacterial Infections | Staphylococcal Skin Infections | Methicillin-Resistant Staphylococcus Aureus

United States, Bulgaria, Chile, Colombia, Georgia, Greece, Guatemala, Latvia, Mexico, Panama, Spain, Ukraine
Forest Laboratories

Completed

Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia

Staphylococcus Aureus Bacteremia | Methicillin-resistant Staphylococcus Aureus (MRSA) Bacteremia

United States
Starship Child Health, Te Toka Tumai Auckland
Menzies School of Health Research; Health Research Council, New Zealand

Not yet recruiting

TREAT-SC: Early, Short Course Oral Dexamethasone for the Treatment of Sydenham Chorea in Children (TREAT-SC)

Rheumatic Fever | Sydenham Chorea

Australia, New Zealand
Stony Brook University
The Plastic Surgery Foundation

Completed

Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction

Breast Implantation | Bacterial Infection | Anti-infective Agents

United States
Harvard Pilgrim Health Care
Centers for Disease Control and Prevention; University of California, Irvine; Agency for Healthcare Research and Quality (AHRQ) and other collaborators

Completed

Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs) (REDUCE-MRSA)

Methicillin-resistant Staphylococcus Aureus

United States
IUATLD, Inc
Medical Research Council; Institute of Tropical Medicine, Belgium; Liverpool... and other collaborators

Completed

The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB (STREAM)

MDR-TB

Ethiopia, Georgia, India, Moldova, Republic of, Mongolia, South Africa, Uganda
NYU Langone Health
National Institute on Minority Health and Health Disparities (NIMHD)

Completed

Patient-Centered Cancer Prevention In Chinese Americans

H. Pylori Infection

United States
GlaxoSmithKline

Completed

Relative Bioavailability Study in Healthy Subjects (PDF112034)

Infections, Bacterial

United States
GlaxoSmithKline

Completed

A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects

Infections, Bacterial

Australia
GlaxoSmithKline

Completed

Single Dose Escalation First Time in Human PK Study

Infections, Bacterial

Australia
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008) (STRIDE-8)

Pneumococcal Infection

United States, Australia, Canada, Chile, Japan, Korea, Republic of, New Zealand, Poland
Pfizer

Completed

Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) (ZEPHYR)

Methicillin Resistant Staphylococcus Aureus (MRSA)

United States, Greece, Colombia, Korea, Republic of, Russian Federation, Turkey, Brazil, Chile, Taiwan, Mexico, Belgium, Spain, Hong Kong, Puerto Rico, France, United Kingdom, Malaysia, Germany, South Africa, Portugal, Argentina, ...
The Medicines Company

Completed

A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Acute Bacterial Skin and Skin Structure Infection

United States
Bio-K Plus International Inc.
Sprim Advanced Life Sciences

Suspended

BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection

Recurrent Clostridium Difficile Infection

United States
University of British Columbia
British Columbia Cancer Agency

Unknown

TB mHealth Study - Use of Cell Phones to Improve Compliance in Patients on LTBI Treatment

Latent Tuberculosis Infection

Canada
Allergan

Completed

Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Bacterial Infections | Acute Bacterial Skin and Skin Structure Infection

United States
Sanofi Pasteur, a Sanofi Company

Recruiting

Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

Healthy Volunteers | Meningococcal Infection

United States, Puerto Rico
Melinta Therapeutics, Inc.
Department of Health and Human Services

Completed

Pharmacokinetics and Safety of Solithromycin in Adolescents and Children

Bacterial Infection

United States, Bulgaria
GlaxoSmithKline

Completed

A Three-Part Study Of GSK580416 In Healthy Subjects

Infections, Bacterial | Respiratory Tract Infection

Australia
Englewood Hospital and Medical Center

Recruiting

Fecal Microbiota Transplantation for C Diff Infection

Clostridium Difficile Infection

United States
Stony Brook University

Completed

Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit

Respiratory Failure | Respiratory Infection | Bacterial Resistance

United States
The University of Queensland
Merck Sharp & Dohme LLC

Withdrawn

Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection (MERINO III)

Bacteremia Caused by Gram-Negative Bacteria

Spain, Australia, Singapore, Italy, Saudi Arabia
GlaxoSmithKline

Completed

Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections

Infections, Bacterial

United States
University of New Mexico
Marquette University

Active, not recruiting

Group B Streptococcus Response After Probiotic Exposure (GRAPE)

Group B Strep Infection

United States
Brahms AG

Terminated

Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection

Sepsis | Infection | Bacterial Infection

United States
Columbia University

Terminated

Effect of Acid Suppression Medication on Pediatric Microbiome

Clostridium Difficile Infection

United States
AtoGen Co. Ltd
ATOGEN AUSTRALIA PTY LTD

Recruiting

Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women

Bacterial Infections | Vaginal Disease | Vaginitis | Infection, Bacterial | Bacterial Vaginosis

Australia
National Institute of Allergy and Infectious Diseases...

Completed

9-valent CRM 197 Pneumococcal

Pneumococcal Infection

United States
Insmed Incorporated

Completed

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex (ARISE)

Mycobacterium Infections, Nontuberculous

United States, Argentina, Australia, Austria, Canada, Chile, Denmark, Germany, Israel, Italy, Korea, Republic of, New Zealand, Spain, Taiwan
Aaron Diamond AIDS Research Center

Completed

Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV

HIV Infections | Mycobacterium Avium-Intracellulare Infection | Tuberculosis, Mycobacterium Infection

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell

United States
Bassett Healthcare

Withdrawn

Use of Bismuth Subsalicylate in Clostridium Difficile Colitis

Clostridium Difficile Infection

United States
Murdoch Childrens Research Institute
Royal Children's Hospital

Completed

What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?

Primary Immunodeficiency | Invasive Pneumococcal Disease, Protection Against | Invasive Pneumococcal Disease, Recurrent Isolated, 1 | Invasive Pneumococcal Disease, Recurrent Isolated, 2

Australia, New Zealand
University Hospital, Essen

Completed

PRetest prObability of Infectious ENDOCARDITIS for Appropriate Criteria Regarding Transesophageal ECHOcardiography in Tertiary Care Facilities (PRO ENDOCARDITIS ECHO-Study)

Infective Endocarditis

Germany

Clinical Trials on Beta Lactam Resistant Bacterial Infection in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations